Company: LGNZZ
Filing Date: 2025-02-25
Form Type: 8-K
Source: 0000886163-25-000003
Chunk: 3

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-02-25
Form: 8-K
Item: Item 9.01
Chunk 3
---
 speak only as of the date of this report. Except as required by law, we disclaim any intent or obligation to update these forward-looking statements beyond the date of this report, even if new information becomes available in the future. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               LIGAND PHARMACEUTICALS INCORPORATED       
  Date: February 25, 2025      By: /s/ Andrew Reardon